UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Abstract P2-12-14: Therapeutic mammoplasty reduces high incomplete excision rate in lobular cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P2-P2-12-14

2016

Volltextzugriff (PDF)

Evaluating HER2 amplification and overexpression in breast cancer

The Journal of pathology, 2001-11, Vol.195 (4), p.422-428

2001

Volltextzugriff (PDF)

Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay

Histology and histopathology, 2024-02, Vol.39 (2), p.177-200

2024

Volltextzugriff (PDF)

Abstract S4-06: HER2 status as predictive marker for AI vs Tam benefit: A TRANS-AIOG meta-analysis of 12129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.S4-S4-06

2016

Volltextzugriff (PDF)

P1-12-05: Complete Pathological Response of Ductal Carcinoma In Situ after Treatment with Neoadjuvant Herceptin

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P1-P1-12-05

2011

Volltextzugriff (PDF)

P3-07-30: Applying the Findings of the Z11 Trial to a UK Practice

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P3-P3-07-30

2011

Volltextzugriff (PDF)

Abstract P6-08-10: Disease Specific Survival of Breast Cancer Patients Is Not Associated with Expression of Inactive or Even Partially Activated Src Kinase

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P6-P6-08-10

2010

Volltextzugriff (PDF)

Abstract P6-08-06: C-Reactive Protein Expression and Its Association with Disease Specific Survival and Disease Recurrence in ER Negative Breast Cancer Patients

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P6-P6-08-06

2010

Volltextzugriff (PDF)

Annexin A8 Is Up-Regulated During Mouse Mammary Gland Involution and Predicts Poor Survival in Breast Cancer

Clinical cancer research, 2005-10, Vol.11 (19), p.6872-6879

2005

Volltextzugriff (PDF)

Determination of HER2 amplification by in situ hybridization: when should chromosome 17 also be determined?

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.3002

2009

Volltextzugriff (PDF)

IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest™ in breast carcinoma

Journal of clinical pathology, 2005-10, Vol.58 (10), p.1086-1090

2005

Volltextzugriff (PDF)

Abstract P3-10-04: An Integration of Biological and Pathological Marker Panel in the TEAM Pathology Sub-Study: The Impact of Different Parameters on Risk Estimation of Relapse at Both 2.75 and 5 Years

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P3-P3-10-04

2010

Volltextzugriff (PDF)

The use of proximity ligation assay to identify HER2:HER3 heterodimers in early breast cancers

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.2068

2009

Volltextzugriff (PDF)

Role of Src family members in breast cancer-dependent on site of phosphorylation

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.2074

2009

Volltextzugriff (PDF)

Is the biology of breast cancer changing? A study of hormone receptor status and grade of breast cancers 1984-1986 and 1996-97

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.3088

2009

Volltextzugriff (PDF)

Phosphorylated c-Src predicts clinical outcome in triple negative breast cancers

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.2076

2009

Volltextzugriff (PDF)

Abstract S2-4: Final Results of a Prospectively Planned Biomarker Analysis: HER1-3 as Predictive Markers of Benefit from Early Treatment with Aromatase Inhibitors Versus Tamoxifen in the TEAM Pathology Sub-Study

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.S2-S2-4

2010

Volltextzugriff (PDF)

Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status

Breast (Edinburgh), 2002-10, Vol.11 (5), p.419-429

2002

Volltextzugriff (PDF)

Effect of hormone replacement therapy on the pathological stage of breast cancer: population based, cross sectional study

BMJ (Online), 2000-02, Vol.320 (7231), p.348

International edition, 2000

Volltextzugriff (PDF)

Optimum number of core biopsies for accurate assessment of histological grade in breast cancer

British journal of surgery, 2002-01, Vol.89 (1), p.84-85

2002

Volltextzugriff (PDF)

Margin assessment by cavity shaving after breast-conserving surgery: analysis and follow-up of 543 patients

European journal of surgical oncology, 1999-10, Vol.25 (5), p.464-469

1999

Volltextzugriff (PDF)

What the clinician needs from the pathologist: Evidence-based reporting in breast cancer

European journal of cancer (1990), 2001-10, Vol.37, p.5-17

2001

Volltextzugriff (PDF)

Relation between socioeconomic deprivation and pathological prognostic factors in women with breast cancer

BMJ (Online), 1994-10, Vol.309 (6961), p.1054

International edition, 1994

Volltextzugriff (PDF)

Ductal carcinoma in situ of the breast – among factors predicting for recurrence, distance from the nipple is important

European journal of surgical oncology, 2001-06, Vol.27 (4), p.373-377

2001

Volltextzugriff (PDF)

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer

British journal of cancer, 1990-12, Vol.62 (6), p.971-975

1990

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract P2-12-14: Therapeutic mammoplasty reduces high incomplete excision rate in lobular cancer

Evaluating HER2 amplification and overexpression in breast cancer

Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay

Abstract S4-06: HER2 status as predictive marker for AI vs Tam benefit: A TRANS-AIOG meta-analysis of 12129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2

P1-12-05: Complete Pathological Response of Ductal Carcinoma In Situ after Treatment with Neoadjuvant Herceptin

P3-07-30: Applying the Findings of the Z11 Trial to a UK Practice

Abstract P6-08-10: Disease Specific Survival of Breast Cancer Patients Is Not Associated with Expression of Inactive or Even Partially Activated Src Kinase

Abstract P6-08-06: C-Reactive Protein Expression and Its Association with Disease Specific Survival and Disease Recurrence in ER Negative Breast Cancer Patients

Annexin A8 Is Up-Regulated During Mouse Mammary Gland Involution and Predicts Poor Survival in Breast Cancer

Determination of HER2 amplification by in situ hybridization: when should chromosome 17 also be determined?

IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest™ in breast carcinoma

Abstract P3-10-04: An Integration of Biological and Pathological Marker Panel in the TEAM Pathology Sub-Study: The Impact of Different Parameters on Risk Estimation of Relapse at Both 2.75 and 5 Years

The use of proximity ligation assay to identify HER2:HER3 heterodimers in early breast cancers

Role of Src family members in breast cancer-dependent on site of phosphorylation

Is the biology of breast cancer changing? A study of hormone receptor status and grade of breast cancers 1984-1986 and 1996-97

Phosphorylated c-Src predicts clinical outcome in triple negative breast cancers

Abstract S2-4: Final Results of a Prospectively Planned Biomarker Analysis: HER1-3 as Predictive Markers of Benefit from Early Treatment with Aromatase Inhibitors Versus Tamoxifen in the TEAM Pathology Sub-Study

Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status

Effect of hormone replacement therapy on the pathological stage of breast cancer: population based, cross sectional study

Optimum number of core biopsies for accurate assessment of histological grade in breast cancer

Margin assessment by cavity shaving after breast-conserving surgery: analysis and follow-up of 543 patients

What the clinician needs from the pathologist: Evidence-based reporting in breast cancer

Relation between socioeconomic deprivation and pathological prognostic factors in women with breast cancer

Ductal carcinoma in situ of the breast – among factors predicting for recurrence, distance from the nipple is important

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer

Suchergebnisse filtern